Navigation Links
3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2012
Date:5/1/2013

SHENYANG, China, May 1, 2013 /PRNewswire/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has filed the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2012 with the U.S. Security and Exchange Commission on April 30, 2013. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at http://www.sec.gov or on the Investor section of the Company's website www.3sbio.com. Shareholders may also receive a hard copy of the annual report free of charge upon request.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China.  Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.  With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see www.3SBio.com for more information.

Investor Contacts

Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
ir@3SBio.com  

Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
'/>"/>

SOURCE 3SBio Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. 3SBio Inc. Adjourns Extraordinary General Meeting of Shareholders
2. 3SBio Inc. Enters Into Merger Agreement For "Going Private" Transaction
3. 3SBio Inc. Announces Unaudited First Quarter 2012 Results
4. 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
5. 3SBio Inc. to Present at the UBS Greater China Conference 2012
6. Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. TNI BioTech Files Form 10 with SEC
9. Marrone Bio Innovations Files Patent for a Unique Bacillus Species
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. NDIS Approval of the Promega PowerPlex(R) Y23 System Enables More Usable Profiles in Less Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015   Regulus Therapeutics Inc . (NASDAQ: ... discovery and development of innovative medicines targeting microRNAs, today ... and Chief Executive Officer of Regulus, will present a ... Annual Healthcare Conference on Wednesday, March 4, 2015 ... at the Boston Marriott Copley Place.  ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 On behalf ... its affiliated companies, Wilentz, Goldman & Spitzer, P.A. ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript’s trade secrets, and that it improperly ... court entered an order denying motions for judgment notwithstanding ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which takes ... Morial Convention Center in New Orleans, Louisiana, will ... 2015) displaying products and services used by the ... The Exposition will offer the latest innovations in ... chemistry; drug discovery; nanotechnology; life sciences to include ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 According ... Research “Agricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast, ... at USD 15,300 million in 2012 and is expected ... a CAGR of 9.5% from 2013 to 2019. ...
Breaking Biology Technology:Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3
... Although the <A , href="http://www.ambion.com/catalog/CatNum.php?1632"> ... were developed for labeling siRNA, they can , ... can be used for this application. See "<A , ... Introduced dsRNA in Cells " for experimintal data using dsRNA , ...
... , May 20, 2002, ... initially considered a bizarre phenomenon limited to petunias and a few ... topics in molecular biology , (<A , ... it has become clear that PTGS occurs in both plants , ...
... border=0 align="left" cellPadding=8 cellSpacing=1>, , ... Assays , Northern Blotting , ... , , ... Yes , Yes , Yes ...
Cached Biology Technology:Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 2Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 3Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit 4RNA Interference and Gene Silencing: History and Overview 2RNA Interference and Gene Silencing: History and Overview 3RNA Interference and Gene Silencing: History and Overview 4RNA Interference and Gene Silencing: History and Overview 5RNA Interference and Gene Silencing: History and Overview 6RNA Interference and Gene Silencing: History and Overview 7RNA Interference and Gene Silencing: History and Overview 8RNA Interference and Gene Silencing: History and Overview 9RNA Interference and Gene Silencing: History and Overview 10RNA Interference and Gene Silencing: History and Overview 11RNA Interference and Gene Silencing: History and Overview 12RNA Interference and Gene Silencing: History and Overview 13RNA Interference and Gene Silencing: History and Overview 14RNA Interference and Gene Silencing: History and Overview 15RNA Interference and Gene Silencing: History and Overview 16RNA Interference and Gene Silencing: History and Overview 17RNA Interference and Gene Silencing: History and Overview 18RNA Interference and Gene Silencing: History and Overview 19RNA Interference and Gene Silencing: History and Overview 20RNA Interference and Gene Silencing: History and Overview 21RNA Interference and Gene Silencing: History and Overview 22RNA Interference and Gene Silencing: History and Overview 23RNA Interference and Gene Silencing: History and Overview 24Comparison of Different Methods of mRNA Quantitation 2Comparison of Different Methods of mRNA Quantitation 3
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... the last decade, Asian farmers have cleared tens of thousands ... demand for palm oil, an increasingly popular food ingredient. Ancient ... cut down. As a result, the landscape of equatorial Asia ... and having a serious impact on the air as well ...
... UC Santa Barbara have made a significant discovery in understanding ... nature,s way of controlling whether these cells will renew, or ... or any other part of the human body. The study ... Cell . The scientists say the finding bodes ...
... flu interventions must be imposed quickly, if they are ... journal BMC Public Health have shown that ... within the home should reduce infection, but only if ... maintained for a relatively long period. Professor George ...
Cached Biology News:NASA study says climate adds fuel to Asian wildfire emissions 2NASA study says climate adds fuel to Asian wildfire emissions 3NASA study says climate adds fuel to Asian wildfire emissions 4Scientists shed light on inner workings of human embryonic stem cells 2Scientists shed light on inner workings of human embryonic stem cells 3Social separation stops flu spread, but must be started soon 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Normal human AB serum, pooled...
Recombinant Human HGF...
Recombinant Mouse MMP-9, CF...
Biology Products: